Status:
RECRUITING
Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation
Lead Sponsor:
Henry Ford Health System
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To study the effect of fractionated 1927-nm non ablative thulium laser in reduction of post inflammatory hyperpigmentation (PIH) using a validated and reproducible model for studying PIH. * Determine...
Detailed Description
The design of the study consists of a total of six visits including one initial screening visit within 107-127 days depending on the scheduling of your screening and subsequent visits. Assessments suc...
Eligibility Criteria
Inclusion
- Patient age 18 and older
- Patient with skin phototypes IV-VI
- Patient able to understand requirements of the study and risks involved
- Patient able to sign a consent form
- Patient to have discontinued all oral medications used to treat pigmentary abnormalities and all topical medications, except for sunscreen, used to treat pigmentary abnormalities on the buttocks one month prior to treatment
Exclusion
- A patient who has skin dyspigmentation, birth marks, tattoos, or other skin findings at baseline on either buttock that may obscure study results
- A patient who is lactating, pregnant, or planning to become pregnant
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06149780
Start Date
November 15 2023
End Date
August 30 2026
Last Update
June 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Medical Center
Detroit, Michigan, United States, 48202